Application of phage display to high throughput antibody generation and characterization von Schofield, Darren J, Pope, Anthony R, Clementel, Veronica, Buckell, Jenny, Chapple, Susan Dj, Clarke, Kay F, Conquer, Jennie S, Crofts, Anna M, Crowther, Sandra R E, Dyson, Michael R, Flack, Gillian, Griffin, Gareth J, Hooks, Yvette, Howat, William J, Kolb-Kokocinski, Anja, Kunze, Susan, Martin, Cecile D, Maslen, Gareth L, Mitchell, Joanne N, O'Sullivan, Maureen, Perera, Rajika L, Roake, Wendy, Shadbolt, S Paul, Vincent, Karen J, Warford, Anthony, Wilson, Wendy E, Xie, Jane, Young, Joyce L, McCafferty, John

Volltext

Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain von DiCara, Danielle M., Chirgadze, Dimitri Y., Pope, Anthony R., Karatt-Vellatt, Aneesh, Winter, Anja, Slavny, Peter, van den Heuvel, Joop, Parthiban, Kothai, Holland, Jane, Packman, Len C., Mavria, Georgia, Hoffmann, Jens, Birchmeier, Walter, Gherardi, Ermanno, McCafferty, John

Volltext

PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma von Homicsko, Krisztian, Zygoura, Panagiota, Norkin, Maxim, Tissot, Stephanie, Shakarishvili, Nicholas, Popat, Sanjay, Curioni-Fontecedro, Alessandra, O'Brien, Mary, Pope, Anthony, Shah, Riyaz, Fisher, Patricia, Spicer, James, Roy, Amy, Gilligan, David, Rusakiewicz, Sylvie, Fortis, Ekaterina, Marti, Nesa, Kammler, Roswitha, Finn, Stephen P, Coukos, Georges, Dafni, Urania, Peters, Solange, Stahel, Rolf A

Volltext

Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library von Vaughan, Tristan J, Williams, Andrew J, Pritchard, Kevin, Osbourn, Jane K, Pope, Anthony R, Earnshaw, John C, McCafferty, John, Hodits, Regina A, Wilton, Jane, Johnson, Kevin S

Volltext

SABR in NSCLC – The beginning of the end or the end of the beginning? von Brada, Michael, Pope, Anthony, Baumann, Michael

Volltext

Incidence of immune checkpoint inhibitor induced myocarditis in patients with mesothelioma from a regional tertiary cancer centre covering a patient population of 2.6 million von Johnson, Alexandra, Chapman, Adam, Garbutt, Nicholas, Griffiths, Richard, Pope, Anthony, Olsson-Brown, Anna Claire

Volltext

Real-world experience of the 6 weekly schedule (q6w) of pembrolizumab in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) von Tariq, Noor-ul-Ain, Anderson, Christian, Gartside, Eleanor, Wong, Helen, Dobson, Lisa, Anthonypillai, Marry, Griffiths, Richard, Pope, Anthony

Volltext

80 - Real-world experience of the 6 weekly schedule (q6w) of pembrolizumab in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) von Tariq, Noor-ul-Ain, Anderson, Christian, Gartside, Eleanor, Wong, Helen, Dobson, Lisa, Anthonypillai, Marry, Griffiths, Richard, Pope, Anthony

Volltext

Association of tertiary lymphoid structures with outcomes from PD-1 inhibition in advanced malignant pleural mesothelioma von Homicsko, Krisztian, Zygoura, Giota, Tissot, Stephanie, Popat, Sanjay, Curioni-Fontecedro, Alessandra, Dellaporta, Tereza, O'Brien, Mary, Pope, Anthony, Shah, Riyaz N.H., Kammler, Rosita, Finn, Stephen P., Coukos, George, Peters, Solange, Stahel, Rolf A.

Volltext

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-lab... von Aix, Santiago Ponce, Ciuleanu, Tudor Eliade, Navarro, Alejandro, Cousin, Sophie, Bonanno, Laura, Smit, Egbert F, Chiappori, Alberto, Olmedo, Maria Eugenia, Horvath, Ildiko, Grohé, Christian, Farago, Anna F, López-Vilariño, José Antonio, Cullell-Young, Martin, Nieto, Antonio, Vasco, Noelia, Gómez, Javier, Kahatt, Carmen, Zeaiter, Ali, Carcereny, Enric, Roubec, Jaromir, Syrigos, Konstantinos, Lo, Gregory, Barneto, Isidoro, Pope, Anthony, Sánchez, Amparo, Kattan, Joseph, Zarogoulidis, Konstantinos, Waller, Cornelius F, Bischoff, Helge, Juan-Vidal, Oscar, Reinmuth, Niels, Dómine, Manuel, Paz-Ares, Luis

Volltext

A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9–15 PROMISE-meso phase III trial von Banna, Giuseppe Luigi, Addeo, Alfredo, Zygoura, Panagiota, Tsourti, Zoi, Popat, Sanjay, Curioni-Fontecedro, Alessandra, Nadal, Ernest, Shah, Riyaz, Pope, Anthony, Fisher, Patricia, Spicer, James, Roy, Amy, Gilligan, David, Gautschi, Oliver, Janthur, Wolf-Dieter, López-Castro, Rafael, Roschitzki-Voser, Heidi, Dafni, Urania, Peters, Solange, Stahel, Rolf A.

Volltext

Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial von Lim, Eric, Waller, David, Lau, Kelvin, Steele, Jeremy, Pope, Anthony, Ali, Clinton, Bilancia, Rocco, Keni, Manjusha, Popat, Sanjay, O'Brien, Mary, Tokaca, Nadza, Maskell, Nick, Stadon, Louise, Fennell, Dean, Nelson, Louise, Edwards, John, Tenconi, Sara, Socci, Laura, Rintoul, Robert C, Wood, Kelly, Stone, Amanda, Muthukumar, Dakshinamoorthy, Ingle, Charlotte, Taylor, Paul, Cove-Smith, Laura, Califano, Raffaele, Summers, Yvonne, Tasigiannopoulos, Zacharias, Bille, Andrea, Shah, Riyaz, Fuller, Elizabeth, Macnair, Andrew, Shamash, Jonathan, Mansy, Talal, Milton, Richard, Koh, Pek, Ionescu, Andreea Alina, Treece, Sarah, Roy, Amy, Middleton, Gary, Kirk, Alan, Harris, Rosie A, Ashton, Kate, Warnes, Barbara, Bridgeman, Emma, Joyce, Katherine, Mills, Nicola, Elliott, Daisy, Farrar, Nicola, Stokes, Elizabeth, Hughes, Vikki, Nicholson, Andrew G, Rogers, Chris A

Volltext

A fully human antibody neutralising biologically active human TGFβ2 for use in therapy von Thompson, Julia E, Vaughan, Tristan J, Williams, Andrew J, Wilton, Jane, Johnson, Kevin S, Bacon, Louise, Green, Jonathan A, Field, Ray, Ruddock, Steven, Martins, Mia, Pope, Anthony R, Tempest, Philip R, Jackson, Ronald H

Volltext

2-Chloro-1-(2,4-dichlorophenyl)-3-(1H-imidazol-1-yl)-2-phenylpropan-1-one hydrochloride, a novel, nonmutagenic antibacterial with specific activity against anaerobic bacteria von Dickens, Jon P, Ellames, George J, Hare, Nigel J, Lawson, Kevin R, McKay, William R, Metters, Anthony P, Myers, Peter L, Pope, Anthony M. S, Upton, Roger M

Volltext

Transfusion‐related acute lung injury complicating acute myeloid leukaemia therapy von McDerra, Joanna S., Lush, Richard J., Pope, Anthony

Volltext

Stroke quiz von Mazumder, Asif Atik, Pope, George Anthony

Volltext

A case of right sided weakness von Mazumder, Asif Atik, Pope, George Anthony

Volltext

Endgames von Mazumde, Asif Atik, Pope, George Anthony, Craythorne, E. E., du Vivier, A. W. P., Fletcher, John

Volltext

ANTIBODIES AGAINST HGF - RECEPTOR AND USES von DI CARA DANIELLE MARIE, MCCAFFERTY JOHN, GHERARDI ERMANNO, POPE ANTHONY RICHARD

Volltext bestellen

ANTIBODIES AGAINST HGF - RECEPTOR AND USES von DI CARA, DANIELLE, MARIE, GHERARDI, ERMANNO, MCCAFFERTY, JOHN, POPE, ANTHONY, RICHARD

Volltext bestellen